| 6Q2W: reference: Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORgamma inverse agonists., Amaudrut J, Argiriadi MA, Barth M, Breinlinger EC, Bressac D, Broqua P, Calderwood DJ, Chatar M, Cusack KP, Gauld SB, Jacquet S, Kamath RV, Kort ME, Lepais V, Luccarini JM, Masson P, Montalbetti C, Mounier L, Potin D, Poupardin O, Rouaud S, Spitzer L, Wallace CD, Bioorg Med Chem Lett. 2019 May 9. pii: S0960-894X(19)30301-4. doi:, 10.1016/j.bmcl.2019.05.015. PMID: 31101472 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).